Christopher Rovaldi, SVP, Program Management and Operations at ACCELERON PHARMA INC (XLRN), sold 3,699 shares at $42.41 ($157K) on 2018-01-02, disclosed to the SEC on 2018-01-04.
Open-market sale of $157k XLRN by SVP, Program Management and Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.41 | 1,433 | $61K | 38.7% |
| 2 | $42.41 | 1,433 | $61K | 38.7% |
| 3 | $42.45 | 833 | $35K | 22.5% |
| Total | $42.42 avg | 3,699 | $157K | 100% |
| Filing → |
| XLRN | SELL | 2018-04-04 | $245K | — | Filing → |
| XLRN | SELL | 2018-01-17 | $495K | — | Filing → |
| XLRN | SELL | 2017-09-14 | $538K | — | Filing → |